sunitinib
pfizer
['sunitinib']
177-lu-octreotate in unresectable progressive pannet was associated with 80% of 12-month pfs, while sunitinib 42% 12-month pfs (randomized, no comparative study) presented by eric baudin at #esmo2022 #net 
Medical Oncologist, GI tumors and NET, @INCMNSZ